Hammer, H.; Hoepner, R.; Friedli, C.; Leib, S.L.; Suter-Riniker, F.; Diem, L.; Kamber, N.; Chan, A.; Salmen, A.; Kamm, C.P.
Comparison of mRNA Vaccinations with BNT162b2 or mRNA-1273 in Anti-CD20-Treated Multiple Sclerosis Patients. Vaccines 2022, 10, 922.
https://doi.org/10.3390/vaccines10060922
AMA Style
Hammer H, Hoepner R, Friedli C, Leib SL, Suter-Riniker F, Diem L, Kamber N, Chan A, Salmen A, Kamm CP.
Comparison of mRNA Vaccinations with BNT162b2 or mRNA-1273 in Anti-CD20-Treated Multiple Sclerosis Patients. Vaccines. 2022; 10(6):922.
https://doi.org/10.3390/vaccines10060922
Chicago/Turabian Style
Hammer, Helly, Robert Hoepner, Christoph Friedli, Stephen L. Leib, Franziska Suter-Riniker, Lara Diem, Nicole Kamber, Andrew Chan, Anke Salmen, and Christian P. Kamm.
2022. "Comparison of mRNA Vaccinations with BNT162b2 or mRNA-1273 in Anti-CD20-Treated Multiple Sclerosis Patients" Vaccines 10, no. 6: 922.
https://doi.org/10.3390/vaccines10060922
APA Style
Hammer, H., Hoepner, R., Friedli, C., Leib, S. L., Suter-Riniker, F., Diem, L., Kamber, N., Chan, A., Salmen, A., & Kamm, C. P.
(2022). Comparison of mRNA Vaccinations with BNT162b2 or mRNA-1273 in Anti-CD20-Treated Multiple Sclerosis Patients. Vaccines, 10(6), 922.
https://doi.org/10.3390/vaccines10060922